Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Rahikainen R. et al, (2020), Angewandte Chemie

The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site

Campeotto I. et al, (2020), mBio, 11

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

Müller K. et al, (2020)

Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation

Howarth M. et al, (2020), Angewandte Chemie International Edition

Combinatorial Tim‐3 and PD‐1 activity sustains antigen‐specific Th1 cell numbers during blood‐stage malaria

Dookie RS. et al, (2020), Parasite Immunology, 42

Structure of the cysteine-rich domain of Plasmodium falciparum P113 identifies the location of the RH5 binding site

Campeotto I. et al, (2020)

The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target

Ragotte RJ. et al, (2020), Trends in Parasitology, 36, 545 - 559

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia

Arezes J. et al, (2020), Blood

Design of a basigin‐mimicking inhibitor targeting the malaria invasion protein RH5

Warszawski S. et al, (2020), Proteins: Structure, Function, and Bioinformatics, 88, 187 - 195

Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL

Labbé GM. et al, (2019), Malaria Journal, 18

Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25

Zaric M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1683 - 1684

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Rawlinson TA. et al, (2019), Nature Microbiology, 4, 1497 - 1507

Adeno-associated viral vectored delivery of a monoclonal antibody gene against blood-stage malaria

Bardelli M. et al, (2019), HUMAN GENE THERAPY, 30, A11 - A11

New strategy of cancer vaccination by a hybrid bacteriophage vector and a malaria vaccine

Waramit S. et al, (2019), HUMAN GENE THERAPY, 30, A13 - A13

Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research

Mohring F. et al, (2019), eLife, 8

Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites

Knuepfer E. et al, (2019), PLOS Pathogens, 15, e1007809 - e1007809

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies

Alanine DGW. et al, (2019), Cell, 178, 216 - 228.e21

A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.

Douglas AD. et al, (2019), Nat Commun, 10

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7

Rapid and iterative genome editing in the zoonotic malaria parasitePlasmodium knowlesi: New tools forP. vivaxresearch

Mohring F. et al, (2019)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?